ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

Pancreatic Cysts - Guidelines Based Management

AdventHealth

V. Shami

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

Neuroendocrine Tumors: Management and Updates

Integrity CE

R. Iyer

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Multidisciplinary Approach to Hepatocellular Carcinoma

UCLA Health

G. Choi, B. Yanny, S. Sadeghi, J. Hui

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Ibrahim Sahin

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Esophageal Cancer Case Discussion: Workup and Updated Treatment Opti…

Yale Cancer Center

P. Kunz, L. Baum, K. Du, S. Khan, J. Kortmansky

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi